Asia-Pacific Travel Vaccine Market to 2032
Overview
The Asia-Pacific Travel Vaccine Market is expected to reach a 2.59 USD Billion by 2032 and is projected to grow at a CAGR of 10.47% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.38
Forecast, 2032 (USD Billion)
2.59
CAGR, 2024 - 2032
10.47%
Report Coverage
Asia-Pacific
Asia-Pacific Travel Vaccine Market 2018-2032 USD Billion
Asia-Pacific Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.38 USD Billion
- Projected Market Size (2032): 2.59 USD Billion
- CAGR (2025-2032): 10.47%
Key Findings of Asia-Pacific Travel Vaccine Market
- The Asia-Pacific Travel Vaccine Market was valued at 1.38 USD Billion in 2024.
- The Asia-Pacific Travel Vaccine Market is likely to grow at a CAGR of 10.47% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 1.14 USD Billion
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 17.63% during the forecast period from 2024 to 2032.
Asia-Pacific Travel Vaccine Market Scope
Asia-Pacific Travel Vaccine Market Segmentation & Scope
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Asia-Pacific Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.38 USD Billion |
| Market Value in 2032 | 2.59 USD Billion |
| CAGR (2025-2032) | 10.47% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Disease,Category,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Type,Composition |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 1.38 USD Billion in 2024
- Key Country: India, leading in terms of revenue with value of 257.75 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in Asia-Pacific Travel Vaccine Market to 2032 with a revenue of 254.65 USD Billion in the year 2024.
- Typhoid is the Fastest growing segment in Asia-Pacific Travel Vaccine Market to 2032 with a Growth rate of 17.63 % in forecast period 2025-2032.
-
Asia-Pacific Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in Asia-Pacific Travel Vaccine Market to 2032 with a revenue of 674.68 USD Billion in the year 2024.
- Recommended Vaccine is the Fastest growing segment in Asia-Pacific Travel Vaccine Market to 2032 with a Growth rate of 10.86 % in forecast period 2025-2032.
-
Asia-Pacific Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in Asia-Pacific Travel Vaccine Market to 2032 with a revenue of 1.08 USD Billion in the year 2024.
- B2B is the Fastest growing segment in Asia-Pacific Travel Vaccine Market to 2032 with a Growth rate of 10.63 % in forecast period 2025-2032.
-
Asia-Pacific Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in Asia-Pacific Travel Vaccine Market to 2032 with a revenue of 715.28 USD Billion in the year 2024.
- 20-50 Years is the Fastest growing segment in Asia-Pacific Travel Vaccine Market to 2032 with a Growth rate of 10.91 % in forecast period 2025-2032.
-
Asia-Pacific Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in Asia-Pacific Travel Vaccine Market to 2032 with a revenue of 655.94 USD Billion in the year 2024.
- Adult is the Fastest growing segment in Asia-Pacific Travel Vaccine Market to 2032 with a Growth rate of 11.08 % in forecast period 2025-2032.
-
Asia-Pacific Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in Asia-Pacific Travel Vaccine Market to 2032 with a revenue of 751.78 USD Billion in the year 2024.
- Male is the Fastest growing segment in Asia-Pacific Travel Vaccine Market to 2032 with a Growth rate of 10.68 % in forecast period 2025-2032.
-
Asia-Pacific Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in Asia-Pacific Travel Vaccine Market to 2032 with a revenue of 1.14 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in Asia-Pacific Travel Vaccine Market to 2032 with a Growth rate of 10.61 % in forecast period 2025-2032.
-
Asia-Pacific Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in Asia-Pacific Travel Vaccine Market to 2032 with a revenue of 430.13 USD Billion in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in Asia-Pacific Travel Vaccine Market to 2032 with a Growth rate of 11.48 % in forecast period 2025-2032.
-
Asia-Pacific Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in Asia-Pacific Travel Vaccine Market to 2032 with a revenue of 966.80 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in Asia-Pacific Travel Vaccine Market to 2032 with a Growth rate of 10.62 % in forecast period 2025-2032.
Asia-Pacific Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
Asia-Pacific Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Billion
Asia-Pacific Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Travel Vaccine Market is segmented based on Segmentation Disease,Category,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Type,Composition.
Asia-Pacific Travel Vaccine Market was valued at USD 1.38(Revenue in USD Billion) in 2022.
Asia-Pacific Travel Vaccine Market is projected to grow at a CAGR of 10.47% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Asia-Pacific Travel Vaccine Market, holding a largest market share of 1.14 USD Billion in 2024
Asia-Pacific Travel Vaccine Market Scope
Asia-Pacific Travel Vaccine Market Segmentation & Scope
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Frequently Asked Questions
The Asia-Pacific Travel Vaccine Market is segmented based on Segmentation Disease,Category,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Type,Composition.
Asia-Pacific Travel Vaccine Market was valued at USD 1.38(Revenue in USD Billion) in 2022.
Asia-Pacific Travel Vaccine Market is projected to grow at a CAGR of 10.47% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Travel Vaccine Market for final year is USD 2.59 (USD Billion).
Asia-Pacific Travel Vaccine Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Travel Vaccine Market is segmented based on Segmentation Disease,Category,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Type,Composition.
Asia-Pacific Travel Vaccine Market was valued at USD 1.38(Revenue in USD Billion) in 2022.
Asia-Pacific Travel Vaccine Market is projected to grow at a CAGR of 10.47% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Travel Vaccine Market for final year is USD 2.59 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.